This report explains the rise of tech-focused SDOH initiatives among US health insurers and hospitals, unpacks how these entities’ heavier focus on SDOH has ushered in opportunities for digital health vendors and tech companies operating at the periphery of healthcare to help address nonclinical health gaps, and lays out the factors driving the prioritization of SDOH and inhibiting these efforts’ growth.

In addition to building next-generation smart network infrastructure, 5G startups are piloting use cases across industries that take advantage of the performance advancements of 5G connections.

5G networks are operating in over 60 countries as of early 2021. This report reviews what the arrival of 5G means and focuses on some of the critical applications that will make it revolutionary.

5G will become one of the most promising technologies for facilitating healthcare’s digital transformation. This report analyzes five patient applications of 5G. It also explores forward-looking organizations embracing 5G and how healthcare organizations can follow in their footsteps.

The spread of the novel coronavirus across the US has driven the evolution of remote patient monitoring (RPM) solutions from nice-to-have to need-to-have. While there’s a rosy path ahead for RPM vendors, a number of roadblocks—like the connectivity divide and laggard doctors—may restrain RPM from reaching its full potential.

Digital therapeutics (DTx) were gaining popularity as tools to help slash the US’ $3 trillion annual spending on chronic disease, and the pandemic has vaulted digital therapies into the spotlight. Now, the Teladoc-Livongo megamerger is heating up competition in the DTx space as players race to capture a slice of a market slated to reach $56 billion by 2025.

The reports in this collection look at ad spending in the retail, financial services, computing products and consumer electronics, automotive, telecom, travel, health and pharma, media and entertainment, and CPG industries. Countries covered in this report series include the US, UK, and Germany.

Digital ad spending in the US healthcare and pharmaceutical industry will grow by 14.2% to reach $9.53 billion in 2020. Growth is being fueled by ads related to COVID-19, including public service announcements, medical supplies and telemedicine.

US B2B digital ad spending in 2020 will grow 22.6% year over year amid the coronavirus pandemic. This report breaks down the market factors and B2B-specific considerations that are driving this increase.

This report provides an overview of the most important technology trends from CES 2020 and what they mean for marketers.